Enhanced clinical effect of rituximab to malignant lymphoma with paroxysmal nocturnal hemoglobinuria

Hiroaki Asai

Presentation information

Poster Session

Sun. Oct, 14

Poster Session 3-6 PNH/Hemolytic anemia

Sun. Oct 14, 2018 1:00 PM - 1:40 PM Poster1 (Osaka International Convention Center, 3F Event Hall)

Chair: Tatsuya Kamaguchi (Kumamoto Health Science University Department of Medical Technology)

[PS3-6-5] Enhanced clinical effect of rituximab to malignant lymphoma with paroxysmal nocturnal hemoglobinuria

Hiroaki Asai¹, Kazuto Takeuchi¹, Yuichi Ikeda², Toshiki Ochi², Kazushi Tanimoto², Jun Yamanouchi², Taichi Azuma², Hiroshi Fujiwara², Takaaki Hato², Masaki Yasukawa², Yoshihiro Yakushijin³ (1.Oncology Center, Ehime Univ. Hospital, Ehime, Japan, 2.Hematology, Clinical Immunology and Infectious Diseases, Ehime Univ., Ehime, Japan, 3.Clinical Oncology, Ehime Univ., Ehime, Japan)

Abstract password authentication.
Password is written on a program and abstract book.